nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR2C—metabolic syndrome X	0.546	1	CbGaD
Pramipexole—SLC22A2—Metformin—metabolic syndrome X	0.137	0.535	CbGbCtD
Pramipexole—SLC22A1—Metformin—metabolic syndrome X	0.119	0.465	CbGbCtD
Pramipexole—HTR2A—arteriole—metabolic syndrome X	0.00601	0.149	CbGeAlD
Pramipexole—Tonsillitis—Metformin—metabolic syndrome X	0.00518	0.064	CcSEcCtD
Pramipexole—Sinus headache—Metformin—metabolic syndrome X	0.00402	0.0496	CcSEcCtD
Pramipexole—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00383	0.0951	CbGeAlD
Pramipexole—Tooth abscess—Metformin—metabolic syndrome X	0.00313	0.0387	CcSEcCtD
Pramipexole—Emotional distress—Metformin—metabolic syndrome X	0.00308	0.0381	CcSEcCtD
Pramipexole—HTR1B—artery—metabolic syndrome X	0.00303	0.0754	CbGeAlD
Pramipexole—HTR1D—artery—metabolic syndrome X	0.00294	0.073	CbGeAlD
Pramipexole—Sinus congestion—Metformin—metabolic syndrome X	0.00263	0.0325	CcSEcCtD
Pramipexole—HTR2A—autonomic nervous system—metabolic syndrome X	0.00257	0.0639	CbGeAlD
Pramipexole—HTR1B—blood vessel—metabolic syndrome X	0.00236	0.0587	CbGeAlD
Pramipexole—HTR1D—blood vessel—metabolic syndrome X	0.00229	0.0569	CbGeAlD
Pramipexole—Toothache—Metformin—metabolic syndrome X	0.00215	0.0266	CcSEcCtD
Pramipexole—Respiratory distress—Metformin—metabolic syndrome X	0.00206	0.0255	CcSEcCtD
Pramipexole—Upset stomach—Metformin—metabolic syndrome X	0.002	0.0247	CcSEcCtD
Pramipexole—Fungal infection—Metformin—metabolic syndrome X	0.0017	0.0209	CcSEcCtD
Pramipexole—Rhinorrhoea—Metformin—metabolic syndrome X	0.00162	0.02	CcSEcCtD
Pramipexole—Chest discomfort—Metformin—metabolic syndrome X	0.00148	0.0183	CcSEcCtD
Pramipexole—Accidental injury—Metformin—metabolic syndrome X	0.00148	0.0183	CcSEcCtD
Pramipexole—HTR2A—artery—metabolic syndrome X	0.00146	0.0363	CbGeAlD
Pramipexole—SLC22A2—kidney—metabolic syndrome X	0.00143	0.0355	CbGeAlD
Pramipexole—HTR2A—endothelium—metabolic syndrome X	0.00123	0.0306	CbGeAlD
Pramipexole—Neuropathy—Metformin—metabolic syndrome X	0.00123	0.0152	CcSEcCtD
Pramipexole—HTR2A—blood vessel—metabolic syndrome X	0.00114	0.0282	CbGeAlD
Pramipexole—Ear pain—Metformin—metabolic syndrome X	0.00111	0.0138	CcSEcCtD
Pramipexole—HTR1B—cardiovascular system—metabolic syndrome X	0.00105	0.0262	CbGeAlD
Pramipexole—Nasal congestion—Metformin—metabolic syndrome X	0.00104	0.0129	CcSEcCtD
Pramipexole—Injury—Metformin—metabolic syndrome X	0.00103	0.0128	CcSEcCtD
Pramipexole—HTR1D—cardiovascular system—metabolic syndrome X	0.00102	0.0254	CbGeAlD
Pramipexole—SLC22A1—kidney—metabolic syndrome X	0.00101	0.025	CbGeAlD
Pramipexole—HTR1D—kidney—metabolic syndrome X	0.000999	0.0248	CbGeAlD
Pramipexole—Renal impairment—Metformin—metabolic syndrome X	0.000998	0.0123	CcSEcCtD
Pramipexole—Hypoglycaemia—Metformin—metabolic syndrome X	0.000974	0.012	CcSEcCtD
Pramipexole—Lethargy—Metformin—metabolic syndrome X	0.00097	0.012	CcSEcCtD
Pramipexole—Pain in extremity—Metformin—metabolic syndrome X	0.00095	0.0117	CcSEcCtD
Pramipexole—HTR2B—cardiovascular system—metabolic syndrome X	0.000949	0.0236	CbGeAlD
Pramipexole—Migraine—Metformin—metabolic syndrome X	0.000935	0.0116	CcSEcCtD
Pramipexole—SLC22A1—adipose tissue—metabolic syndrome X	0.000908	0.0226	CbGeAlD
Pramipexole—Dehydration—Metformin—metabolic syndrome X	0.000884	0.0109	CcSEcCtD
Pramipexole—Abdominal pain upper—Metformin—metabolic syndrome X	0.000868	0.0107	CcSEcCtD
Pramipexole—Breast disorder—Metformin—metabolic syndrome X	0.000859	0.0106	CcSEcCtD
Pramipexole—Cramp muscle—Metformin—metabolic syndrome X	0.000856	0.0106	CcSEcCtD
Pramipexole—HTR1A—cardiovascular system—metabolic syndrome X	0.000851	0.0211	CbGeAlD
Pramipexole—Nasopharyngitis—Metformin—metabolic syndrome X	0.00085	0.0105	CcSEcCtD
Pramipexole—HTR2B—adipose tissue—metabolic syndrome X	0.000837	0.0208	CbGeAlD
Pramipexole—Abdominal distension—Metformin—metabolic syndrome X	0.000827	0.0102	CcSEcCtD
Pramipexole—Influenza—Metformin—metabolic syndrome X	0.000821	0.0101	CcSEcCtD
Pramipexole—Pancreatitis—Metformin—metabolic syndrome X	0.000805	0.00995	CcSEcCtD
Pramipexole—Angina pectoris—Metformin—metabolic syndrome X	0.0008	0.00989	CcSEcCtD
Pramipexole—Abdominal discomfort—Metformin—metabolic syndrome X	0.000787	0.00973	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000763	0.00943	CcSEcCtD
Pramipexole—Infestation NOS—Metformin—metabolic syndrome X	0.000732	0.00905	CcSEcCtD
Pramipexole—Infestation—Metformin—metabolic syndrome X	0.000732	0.00905	CcSEcCtD
Pramipexole—Drowsiness—Metformin—metabolic syndrome X	0.000732	0.00905	CcSEcCtD
Pramipexole—ADRA2C—kidney—metabolic syndrome X	0.000731	0.0182	CbGeAlD
Pramipexole—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000718	0.00887	CcSEcCtD
Pramipexole—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000693	0.00856	CcSEcCtD
Pramipexole—Bradycardia—Metformin—metabolic syndrome X	0.000669	0.00827	CcSEcCtD
Pramipexole—Rhinitis—Metformin—metabolic syndrome X	0.000659	0.00814	CcSEcCtD
Pramipexole—ADRA2C—adipose tissue—metabolic syndrome X	0.000659	0.0164	CbGeAlD
Pramipexole—Hypoaesthesia—Metformin—metabolic syndrome X	0.000654	0.00808	CcSEcCtD
Pramipexole—Oedema peripheral—Metformin—metabolic syndrome X	0.000648	0.008	CcSEcCtD
Pramipexole—Connective tissue disorder—Metformin—metabolic syndrome X	0.000646	0.00798	CcSEcCtD
Pramipexole—SLC22A1—liver—metabolic syndrome X	0.000637	0.0158	CbGeAlD
Pramipexole—Eye disorder—Metformin—metabolic syndrome X	0.000614	0.00759	CcSEcCtD
Pramipexole—Flushing—Metformin—metabolic syndrome X	0.00061	0.00754	CcSEcCtD
Pramipexole—Cardiac disorder—Metformin—metabolic syndrome X	0.00061	0.00754	CcSEcCtD
Pramipexole—Angiopathy—Metformin—metabolic syndrome X	0.000596	0.00737	CcSEcCtD
Pramipexole—Immune system disorder—Metformin—metabolic syndrome X	0.000594	0.00734	CcSEcCtD
Pramipexole—Mediastinal disorder—Metformin—metabolic syndrome X	0.000592	0.00732	CcSEcCtD
Pramipexole—Chills—Metformin—metabolic syndrome X	0.00059	0.00729	CcSEcCtD
Pramipexole—Malnutrition—Metformin—metabolic syndrome X	0.000572	0.00707	CcSEcCtD
Pramipexole—Erythema—Metformin—metabolic syndrome X	0.000572	0.00707	CcSEcCtD
Pramipexole—Flatulence—Metformin—metabolic syndrome X	0.000564	0.00697	CcSEcCtD
Pramipexole—Dysgeusia—Metformin—metabolic syndrome X	0.00056	0.00693	CcSEcCtD
Pramipexole—Muscle spasms—Metformin—metabolic syndrome X	0.00055	0.0068	CcSEcCtD
Pramipexole—Vision blurred—Metformin—metabolic syndrome X	0.000539	0.00666	CcSEcCtD
Pramipexole—Tremor—Metformin—metabolic syndrome X	0.000536	0.00663	CcSEcCtD
Pramipexole—Ill-defined disorder—Metformin—metabolic syndrome X	0.000531	0.00656	CcSEcCtD
Pramipexole—ADRA2A—adipose tissue—metabolic syndrome X	0.000526	0.0131	CbGeAlD
Pramipexole—Malaise—Metformin—metabolic syndrome X	0.000516	0.00638	CcSEcCtD
Pramipexole—Syncope—Metformin—metabolic syndrome X	0.000513	0.00634	CcSEcCtD
Pramipexole—HTR2A—cardiovascular system—metabolic syndrome X	0.000507	0.0126	CbGeAlD
Pramipexole—Palpitations—Metformin—metabolic syndrome X	0.000506	0.00625	CcSEcCtD
Pramipexole—Loss of consciousness—Metformin—metabolic syndrome X	0.000503	0.00622	CcSEcCtD
Pramipexole—HTR2A—kidney—metabolic syndrome X	0.000496	0.0123	CbGeAlD
Pramipexole—Hypertension—Metformin—metabolic syndrome X	0.000494	0.00611	CcSEcCtD
Pramipexole—Myalgia—Metformin—metabolic syndrome X	0.000487	0.00602	CcSEcCtD
Pramipexole—Chest pain—Metformin—metabolic syndrome X	0.000487	0.00602	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000484	0.00598	CcSEcCtD
Pramipexole—Discomfort—Metformin—metabolic syndrome X	0.000481	0.00595	CcSEcCtD
Pramipexole—Oedema—Metformin—metabolic syndrome X	0.000467	0.00577	CcSEcCtD
Pramipexole—Infection—Metformin—metabolic syndrome X	0.000464	0.00573	CcSEcCtD
Pramipexole—ADRA2C—liver—metabolic syndrome X	0.000462	0.0115	CbGeAlD
Pramipexole—Shock—Metformin—metabolic syndrome X	0.000459	0.00568	CcSEcCtD
Pramipexole—Nervous system disorder—Metformin—metabolic syndrome X	0.000458	0.00566	CcSEcCtD
Pramipexole—Thrombocytopenia—Metformin—metabolic syndrome X	0.000457	0.00565	CcSEcCtD
Pramipexole—Skin disorder—Metformin—metabolic syndrome X	0.000454	0.00561	CcSEcCtD
Pramipexole—Hyperhidrosis—Metformin—metabolic syndrome X	0.000451	0.00558	CcSEcCtD
Pramipexole—Anorexia—Metformin—metabolic syndrome X	0.000445	0.0055	CcSEcCtD
Pramipexole—Hypotension—Metformin—metabolic syndrome X	0.000436	0.00539	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000425	0.00526	CcSEcCtD
Pramipexole—Paraesthesia—Metformin—metabolic syndrome X	0.000419	0.00518	CcSEcCtD
Pramipexole—Dyspnoea—Metformin—metabolic syndrome X	0.000416	0.00515	CcSEcCtD
Pramipexole—Somnolence—Metformin—metabolic syndrome X	0.000415	0.00513	CcSEcCtD
Pramipexole—Dyspepsia—Metformin—metabolic syndrome X	0.000411	0.00508	CcSEcCtD
Pramipexole—Decreased appetite—Metformin—metabolic syndrome X	0.000406	0.00502	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000403	0.00498	CcSEcCtD
Pramipexole—Fatigue—Metformin—metabolic syndrome X	0.000403	0.00498	CcSEcCtD
Pramipexole—Constipation—Metformin—metabolic syndrome X	0.000399	0.00494	CcSEcCtD
Pramipexole—Feeling abnormal—Metformin—metabolic syndrome X	0.000385	0.00476	CcSEcCtD
Pramipexole—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000382	0.00472	CcSEcCtD
Pramipexole—Urticaria—Metformin—metabolic syndrome X	0.000371	0.00458	CcSEcCtD
Pramipexole—Abdominal pain—Metformin—metabolic syndrome X	0.000369	0.00456	CcSEcCtD
Pramipexole—Asthenia—Metformin—metabolic syndrome X	0.000335	0.00414	CcSEcCtD
Pramipexole—Pruritus—Metformin—metabolic syndrome X	0.00033	0.00408	CcSEcCtD
Pramipexole—Diarrhoea—Metformin—metabolic syndrome X	0.00032	0.00395	CcSEcCtD
Pramipexole—HTR2A—liver—metabolic syndrome X	0.000314	0.00779	CbGeAlD
Pramipexole—Dizziness—Metformin—metabolic syndrome X	0.000309	0.00382	CcSEcCtD
Pramipexole—Vomiting—Metformin—metabolic syndrome X	0.000297	0.00367	CcSEcCtD
Pramipexole—Rash—Metformin—metabolic syndrome X	0.000294	0.00364	CcSEcCtD
Pramipexole—Dermatitis—Metformin—metabolic syndrome X	0.000294	0.00364	CcSEcCtD
Pramipexole—Headache—Metformin—metabolic syndrome X	0.000293	0.00362	CcSEcCtD
Pramipexole—Nausea—Metformin—metabolic syndrome X	0.000277	0.00343	CcSEcCtD
Pramipexole—DRD1—Signaling Pathways—APOE—metabolic syndrome X	1.29e-05	0.000168	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—APOE—metabolic syndrome X	1.28e-05	0.000168	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—LPL—metabolic syndrome X	1.28e-05	0.000167	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IRS1—metabolic syndrome X	1.28e-05	0.000167	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—APOA1—metabolic syndrome X	1.28e-05	0.000167	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TGFB1—metabolic syndrome X	1.27e-05	0.000166	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—LEP—metabolic syndrome X	1.27e-05	0.000166	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—APOE—metabolic syndrome X	1.27e-05	0.000166	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—INS—metabolic syndrome X	1.27e-05	0.000166	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—APOA1—metabolic syndrome X	1.27e-05	0.000166	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PLA2G4A—metabolic syndrome X	1.27e-05	0.000166	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—APOA1—metabolic syndrome X	1.26e-05	0.000164	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AGT—metabolic syndrome X	1.26e-05	0.000164	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF2—metabolic syndrome X	1.25e-05	0.000164	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CCL2—metabolic syndrome X	1.25e-05	0.000163	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—AKT1—metabolic syndrome X	1.25e-05	0.000163	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—INS—metabolic syndrome X	1.24e-05	0.000162	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—LPL—metabolic syndrome X	1.24e-05	0.000162	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CCL2—metabolic syndrome X	1.24e-05	0.000162	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF2—metabolic syndrome X	1.23e-05	0.000161	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—APOE—metabolic syndrome X	1.23e-05	0.000161	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IGF1—metabolic syndrome X	1.23e-05	0.000161	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—IL6—metabolic syndrome X	1.23e-05	0.00016	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—INS—metabolic syndrome X	1.23e-05	0.00016	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CCL2—metabolic syndrome X	1.22e-05	0.00016	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IRS1—metabolic syndrome X	1.22e-05	0.000159	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—APOB—metabolic syndrome X	1.22e-05	0.000159	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—APOA1—metabolic syndrome X	1.22e-05	0.000159	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CCL2—metabolic syndrome X	1.21e-05	0.000157	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IGF1—metabolic syndrome X	1.2e-05	0.000157	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—APOB—metabolic syndrome X	1.2e-05	0.000156	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCL5—metabolic syndrome X	1.19e-05	0.000155	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IGF1—metabolic syndrome X	1.18e-05	0.000155	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.18e-05	0.000155	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CD36—metabolic syndrome X	1.18e-05	0.000154	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AGT—metabolic syndrome X	1.17e-05	0.000153	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL5—metabolic syndrome X	1.17e-05	0.000153	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—INS—metabolic syndrome X	1.17e-05	0.000153	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—AKT1—metabolic syndrome X	1.17e-05	0.000152	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SERPINE1—metabolic syndrome X	1.17e-05	0.000152	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.17e-05	0.000152	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—LPL—metabolic syndrome X	1.16e-05	0.000152	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IRS1—metabolic syndrome X	1.15e-05	0.00015	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CCL2—metabolic syndrome X	1.15e-05	0.00015	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PPARG—metabolic syndrome X	1.15e-05	0.00015	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—LEP—metabolic syndrome X	1.15e-05	0.00015	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—APOE—metabolic syndrome X	1.15e-05	0.00015	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—LPL—metabolic syndrome X	1.14e-05	0.000149	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.14e-05	0.000149	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—APOA1—metabolic syndrome X	1.14e-05	0.000148	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IRS1—metabolic syndrome X	1.14e-05	0.000148	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AGT—metabolic syndrome X	1.13e-05	0.000148	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—AKT1—metabolic syndrome X	1.13e-05	0.000148	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IGF1—metabolic syndrome X	1.13e-05	0.000148	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—INS—metabolic syndrome X	1.13e-05	0.000147	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AGT—metabolic syndrome X	1.13e-05	0.000147	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SERPINE1—metabolic syndrome X	1.13e-05	0.000147	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF2—metabolic syndrome X	1.12e-05	0.000147	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PPARG—metabolic syndrome X	1.12e-05	0.000146	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NOS3—metabolic syndrome X	1.11e-05	0.000146	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—LEP—metabolic syndrome X	1.11e-05	0.000145	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—APOE—metabolic syndrome X	1.11e-05	0.000145	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—APOE—metabolic syndrome X	1.1e-05	0.000144	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—LEP—metabolic syndrome X	1.1e-05	0.000144	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—INS—metabolic syndrome X	1.1e-05	0.000144	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PPARA—metabolic syndrome X	1.1e-05	0.000144	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—INS—metabolic syndrome X	1.1e-05	0.000143	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—APOA1—metabolic syndrome X	1.1e-05	0.000143	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AGT—metabolic syndrome X	1.1e-05	0.000143	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—APOA1—metabolic syndrome X	1.09e-05	0.000142	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NOS3—metabolic syndrome X	1.09e-05	0.000142	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—AKT1—metabolic syndrome X	1.09e-05	0.000142	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	1.09e-05	0.000142	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—INS—metabolic syndrome X	1.09e-05	0.000142	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CCL2—metabolic syndrome X	1.09e-05	0.000142	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NOS3—metabolic syndrome X	1.07e-05	0.00014	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—LEP—metabolic syndrome X	1.07e-05	0.00014	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.07e-05	0.00014	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—APOE—metabolic syndrome X	1.07e-05	0.00014	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PPARG—metabolic syndrome X	1.07e-05	0.00014	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CCL2—metabolic syndrome X	1.07e-05	0.00014	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IGF1—metabolic syndrome X	1.07e-05	0.000139	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AGT—metabolic syndrome X	1.06e-05	0.000139	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	1.06e-05	0.000139	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—APOA1—metabolic syndrome X	1.06e-05	0.000139	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.06e-05	0.000138	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IGF1—metabolic syndrome X	1.05e-05	0.000137	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—INS—metabolic syndrome X	1.05e-05	0.000137	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—APOE—metabolic syndrome X	1.04e-05	0.000136	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	1.04e-05	0.000136	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ALB—metabolic syndrome X	1.03e-05	0.000135	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—APOA1—metabolic syndrome X	1.03e-05	0.000135	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IRS1—metabolic syndrome X	1.03e-05	0.000134	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NOS3—metabolic syndrome X	1.03e-05	0.000134	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.01e-05	0.000132	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ALB—metabolic syndrome X	1.01e-05	0.000131	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SERPINE1—metabolic syndrome X	1e-05	0.00013	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AGT—metabolic syndrome X	9.95e-06	0.00013	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	9.9e-06	0.000129	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—NOS3—metabolic syndrome X	9.89e-06	0.000129	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	9.85e-06	0.000129	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—INS—metabolic syndrome X	9.82e-06	0.000128	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	9.79e-06	0.000128	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—LEP—metabolic syndrome X	9.75e-06	0.000127	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—APOE—metabolic syndrome X	9.75e-06	0.000127	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NOS3—metabolic syndrome X	9.67e-06	0.000126	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCL2—metabolic syndrome X	9.67e-06	0.000126	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ALB—metabolic syndrome X	9.64e-06	0.000126	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	9.64e-06	0.000126	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TGFB1—metabolic syndrome X	9.63e-06	0.000126	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—NOS3—metabolic syndrome X	9.62e-06	0.000126	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	9.59e-06	0.000125	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	9.59e-06	0.000125	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	9.58e-06	0.000125	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—AKT1—metabolic syndrome X	9.55e-06	0.000125	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NOS3—metabolic syndrome X	9.54e-06	0.000125	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	9.5e-06	0.000124	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—INS—metabolic syndrome X	9.48e-06	0.000124	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	9.48e-06	0.000124	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—INS—metabolic syndrome X	9.43e-06	0.000123	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—IL6—metabolic syndrome X	9.4e-06	0.000123	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	9.36e-06	0.000122	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	9.33e-06	0.000122	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	9.28e-06	0.000121	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—NOS3—metabolic syndrome X	9.22e-06	0.00012	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL6—metabolic syndrome X	9.21e-06	0.00012	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—AKT1—metabolic syndrome X	9.21e-06	0.00012	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	9.18e-06	0.00012	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	9.17e-06	0.00012	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	9.13e-06	0.000119	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PPARG—metabolic syndrome X	9.09e-06	0.000119	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL6—metabolic syndrome X	9.06e-06	0.000118	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PTGS2—metabolic syndrome X	9.05e-06	0.000118	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	9.03e-06	0.000118	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	9.02e-06	0.000118	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—INS—metabolic syndrome X	8.91e-06	0.000116	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	8.9e-06	0.000116	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	8.88e-06	0.000116	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	8.86e-06	0.000116	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	8.8e-06	0.000115	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—AKT1—metabolic syndrome X	8.79e-06	0.000115	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	8.73e-06	0.000114	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	8.73e-06	0.000114	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.71e-06	0.000114	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	8.69e-06	0.000113	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	8.68e-06	0.000113	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	8.67e-06	0.000113	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL6—metabolic syndrome X	8.65e-06	0.000113	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	8.63e-06	0.000113	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	8.62e-06	0.000112	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	8.56e-06	0.000112	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	8.5e-06	0.000111	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTGS2—metabolic syndrome X	8.44e-06	0.00011	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	8.43e-06	0.00011	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	8.36e-06	0.000109	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—INS—metabolic syndrome X	8.33e-06	0.000109	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	8.32e-06	0.000109	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	8.29e-06	0.000108	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	8.27e-06	0.000108	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—INS—metabolic syndrome X	8.19e-06	0.000107	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	8.19e-06	0.000107	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	8.18e-06	0.000107	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ALB—metabolic syndrome X	8.17e-06	0.000107	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	8.16e-06	0.000106	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	8.06e-06	0.000105	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	8.05e-06	0.000105	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	8.05e-06	0.000105	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	8.05e-06	0.000105	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	7.98e-06	0.000104	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	7.92e-06	0.000103	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—NOS3—metabolic syndrome X	7.82e-06	0.000102	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	7.78e-06	0.000102	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	7.65e-06	9.98e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	7.53e-06	9.82e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.53e-06	9.82e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	7.45e-06	9.73e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	7.43e-06	9.69e-05	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	7.38e-06	9.64e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	7.37e-06	9.62e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	7.33e-06	9.57e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	7.3e-06	9.53e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	7.27e-06	9.48e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—metabolic syndrome X	7.25e-06	9.47e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	7.22e-06	9.42e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	7.21e-06	9.41e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	7.18e-06	9.38e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	7.15e-06	9.33e-05	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.13e-06	9.3e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	7.1e-06	9.27e-05	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	7.09e-06	9.25e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	7.01e-06	9.16e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	6.98e-06	9.11e-05	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	6.9e-06	9e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	6.85e-06	8.94e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	6.79e-06	8.86e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	6.78e-06	8.85e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	6.7e-06	8.75e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—AKT1—metabolic syndrome X	6.69e-06	8.73e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	6.54e-06	8.53e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	6.47e-06	8.45e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	6.44e-06	8.4e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	6.4e-06	8.35e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	6.31e-06	8.24e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	6.26e-06	8.17e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	6.26e-06	8.17e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	6.16e-06	8.04e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.16e-06	8.04e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	6.06e-06	7.91e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	5.7e-06	7.44e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	5.68e-06	7.42e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.6e-06	7.31e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	5.59e-06	7.3e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	5.56e-06	7.25e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	5.51e-06	7.2e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.5e-06	7.18e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	5.47e-06	7.14e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	5.44e-06	7.1e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—metabolic syndrome X	5.35e-06	6.99e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	5.32e-06	6.95e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	5.13e-06	6.69e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	5.11e-06	6.67e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	5.09e-06	6.64e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	5.02e-06	6.55e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	4.94e-06	6.45e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	4.83e-06	6.3e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—metabolic syndrome X	4.82e-06	6.29e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—metabolic syndrome X	4.75e-06	6.21e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	4.75e-06	6.2e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	4.71e-06	6.15e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—AKT1—metabolic syndrome X	4.55e-06	5.94e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	4.45e-06	5.8e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—AKT1—metabolic syndrome X	4.42e-06	5.77e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	4.39e-06	5.73e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	4.32e-06	5.64e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	4.29e-06	5.6e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AKT1—metabolic syndrome X	4.24e-06	5.53e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	4.14e-06	5.41e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	4.12e-06	5.38e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	4.01e-06	5.23e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	3.96e-06	5.17e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	3.82e-06	4.99e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	3.8e-06	4.96e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	3.7e-06	4.83e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6—metabolic syndrome X	3.64e-06	4.75e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AKT1—metabolic syndrome X	3.59e-06	4.69e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	3.58e-06	4.67e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	3.36e-06	4.38e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	3.3e-06	4.31e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	3.26e-06	4.25e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	3e-06	3.92e-05	CbGpPWpGaD
